SUMMARY Six patients with coexistent antiglomerular basement membrane disease and granular immunoreactants in the glomerular basement membrane and mesangium are discussed. These six patients represent 35% of all patients with antiglomerular basement membrane nephritis examined over 10 years. All patients presented with acute, oliguric renal failure, and rapid deterioration in renal function. In all patients the pathogenetic role of the antiglomerular basement membrane antibody was confirmed by the demonstration of linear deposits of IgG along the glomerular basement membrane and antiglomerular basement membrane antibody activity in the serum or renal eluates, or both. Evidence for the existence of concurrent immune aggregates was obtained by immunofluorescence studies and electron microscopy. Radioimmunoassays, which were performed in two patients to detect circulating immune complexes, however, yielded negative results. The possible mechanisms concerned in the evolution of this condition and their potential implications are reviewed.
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Two major nephritogenic immune mechanisms have been implicated in the causation of human glomerulonephritis: the specific interaction of antibodies with antigens that are intrinsic to the glomerular basement membrane (GBM) and the lodging of circulating, nonglomerular, antigenantibody complexes in the glomerulus. Traditionally, glomerulonephritis has been thought to result from either one of these mechanisms, but not both. Anti-GBM nephritis comprises about 2-5%, and immune complex nephritis about 70-80% of all immunologically mediated glomerulonephritis.' 2 Although much information has been gathered about the pathogenesis of anti-GBM disease, little information is available on the factors that are responsible for the induction of anti-GBM antibody. Recently, a few patients with features of both immune complex nephritis and anti-GBM antibody mediated nephritis have been described,"'7 raising the possibility of yet another range of clinicopathological entities. This report describes the immunopathological features of six patients who had both anti-GBM disease and granular immunoreactants in glomeruli.
Material and methods
A total of 1956 consecutive renal biopsy specimens were examined over 10 years from 1972 to 1982. Seventeen specimens (0 9%) fulfilled the clinical, morphological, and immunopathological criteria for anti-GBM disease.'4 Six of these 17 (35%) also showed evidence of deposition of immunoreactants in the kidneys. These six cases are discussed in this report. Whole kidneys were also available for study in four of these patients.
The procedures for processing tissue for light, immunofluorescence, and electron microscopy; the controls for ascertaining the specificity of the reagents used; and the instruments for assessing tissue changes were similar to those described in an earlier 176 Some observations on three of our patients (cases 1, 2, and 3) have already been published.'9
Results
The six patients (five men and one woman) were between 21 and 70 years of age with a mean age of 54 years (Table 1 ). All patients had had manifest renal disease for only a short period (1-12 weeks). All patients presented with acute oliguric renal failure and rapid deterioration in renal function that required dialysis. In addition, two patients presented with dyspnoea and haemoptysis. All patients exhibited a nephritic urinary sediment, with slight proteinuria, and five were hypertensive (diastolic pressure > 90 mm Hg). None of these patients had the nephrotic syndrome. Serum C3 or C4, or both, was measured in three patients, and two had normal complement concentrations. A low serum C3 con-, * # its t '^ffi -* tAs centration, along with a high antistreptolysin 0 titre, was found in one patient (case 2).
Three patients died as a result of extrarenal complications (cases 1, 3, and 5), one of them after renal transplantation (case 3). No patient had vasculitis. Other features are summarised in Table 1. LIGHT MICROSCOPY All six biopsy specimens showed classic histopathological features of crescentic glomerulonephritis ( Fig. 1 and Table 2 ).
IMMUNOPATHOLOGY
The immunofluorescence findings are summarised in Table 3 . Biopsy specimens from all six patients showed sharp, continuous, linear deposits of IgG (3+) (Fig. 2) , and all but one had IgM deposits ( 1 +) along the GBM. The accompanying C3 deposits were similarly linear (1-3+) in three biopsy specimens, whereas interrupted, short linear deposits (1-2+) were seen in one biopsy specimen, and short linear and granular deposits (2+) were noted in another; exclusively granular deposits of C3 (1+) were seen in a single biopsy specimen (Fig. 3) . All the C3 deposits were found mostly along the capillary basement membranes. The ultrastructural findings are summarised in Table  4 . Scattered, definitive, electron dense deposits conforming to immunoreactants were seen in a random 
Case no
IgG IgM distribution ( Fig. 4 and 5) . Subepithelial deposits were found in three of the six specimens, subendothelial deposits in three of them, intramembranous deposits in five, and mesangial deposits in three. The patterns of deposition did not correspond to any typical category of immune complex mediated nephritis. The uninvolved basement membranes showed non-specific features commonly seen in uncomplicated anti-GBM disease. 
Discussion
Anti-GBM disease comprises about 2-5% of immunologically mediated human glomerulonephritides. Diagnosis rests on detection of antibodies bound to the GBM in a continuous, linear configuration and demonstration of anti-GBM activity in sera or renal eluates, or both. In the past decade several reports have emphas- Immunofluorescence showed granular deposits in only two of these patients.
The temporal relation between the deposition of immunoreactants and anti-GBM antibody production in our patients could not be ascertained because Our study focused on an interesting and rare finding that may bear important pathogenetic connotations that are, as yet, undefined. We suspect that with increasing awareness similar pathological entities will be identified more often, and we propose that prospective investigative studies should include serial assays of anti-GBM antibody and circulating immune complexes in the serum to define the temporal relation of this association. If branes might afford an opportunity to gain some insight into the antigen(s) and antibodies that are concerned. Until then, and also until the specificity of the antibody to the putative antigen(s) has been determined, the association of anti-GBM disease and immune complex nephritis will remain a clinical curiosity to challenge the immunopathologist.
